Author: Puebla Patricia Pastoriza Pilar Barcia Emilia Fernández-Carballido Ana
Publisher: Informa Healthcare
ISSN: 1464-5246
Source: Journal of Microencapsulation, Vol.22, Iss.7, 2005-11, pp. : 793-808
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The aim of this study was to obtain biodegradable indomethacin microspheres for intra-articular administration in rheumatoid arthritis, where angiogenic processes are involved. Indomethacin concentrations to achieve an anti-angiogenic effect would be five-times higher than an anti-inflammatory. Microspheres were prepared by solvent evaporation using PLGA. Indomethacin is a poor water-soluble drug with it being possible that dissolved and non-dissolved drug co-exist within the polymeric matrix resulting in rapid release. To control this release, an oil-PEG-derivative was incorporated, producing changes in morphology, crystallinity and indomethacin release. To minimize the amount of microspheres administered, a two-factor five-level central rotable composite 2 2 ?+?star design was employed with two independent variables: indomethacin percentage and PEG-derivative percentage. The optimum formulation showed mean encapsulation efficiency of 94.3?±?2.2% and released 7.99?±?0.25?µg indomethacin/day/mg microspheres for 21 days. A dose of 20–50?mg of this formulation could be appropriate to achieve both anti-angiogenic and anti-inflammatory effects. Preliminary cytotoxicity studies performed in rat splenocytes showed an adequate cell viability.
Related content
By Migliore Alberto Tormenta Sandro Massafra Umberto Bizzi Emanuele Iannessi Francesca Alimonti Andrea Granata Mauro
Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. :